pharma · Steroid refractory Acute Graft versus host Disease · moderate to severe atopic dermatitis
Medac Gesellschaft fuer
Medac Gesellschaft fuer klinische Spezialpraeparate mbH
Medac Gesellschaft fuer is a pharma organization headquartered in EU. Primary therapeutic focus areas include Steroid refractory Acute Graft versus host Disease, moderate to severe atopic dermatitis. NovaPharmaNews links
Company details
- Status
- Public
- HQ
- EU
- Programs
- 3
- Drugs
- 14
- Patents
- 0
MC-FludT.18/QT
Phase 1 · other · Subjects with AML ( Acute myeloid leukaemia) or MDS (Myelodysplastic syndrome) undergoing allogeneic hematopoietic stem cell transplantation
MC-FludT.18/QT for Subjects with AML ( Acute myeloid leukaemia) or MDS (Myelodysplastic syndrome) undergoing allogeneic hematopoietic stem cell transplantation is a Phase 1 program (other) at Medac Gesellschaft fuer klinische Spezialpraeparate mbH with 1 ClinicalTrials.gov record(s).
Internal code MC-FludT.18/QT
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Medac Gesellschaft fuer klinische Spezialpraeparate mbH
- Phase
- Phase 1
- Modality
- other
- Indication
- Subjects with AML ( Acute myeloid leukaemia) or MDS (Myelodysplastic syndrome) undergoing allogeneic hematopoietic stem cell transplantation
- Status
- active
- Trials
- 1